The Full Wiki

Trimethobenzamide: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
CAS number 138-56-7
ATC code none
PubChem 5577
DrugBank APRD01277
Chemical data
Formula C 21H28N2O5  
Mol. mass 388.458 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 7 to 9 hours (mean)
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status -only (US)
Routes Oral, rectal, intramuscular
 Yes check.svgY(what is this?)  (verify)

Trimethobenzamide (Tebamide, Tigan) is an antiemetic used to prevent nausea and vomiting. It is often prescribed for patients with gastroenteritis, medication-induced nausea, and other illnesses. Trimethobenzamide is generally considered the most potent antiemetic that does not have effects on the serotonergic, dopaminergic, or histaminergic systems, so it has a lower likelihood of causing undesired side effects. In the United States, it requires a prescription.


Mechanism of action

Although the specific mechanism through which trimethobenzamide functions is unknown, it is believed to affect the chemoreceptor trigger zone (CTZ) of the medulla oblongata.

Side effects

Possible side effects include drowsiness, dizziness, headache, diarrhea, muscle cramps, and blurred vision. More serious adverse effects include skin rash, tremors, parkinsonism, and jaundice.


Trimethobenzamide is marketed under the brand names Tebamide and Tigan, manufactured by GlaxoSmithKline and King Pharmaceuticals, respectively. It is available as oral capsules and injectable formulations.

Trimethobenzamide was also available as a rectal suppository, but such formulations were banned by the U.S. Food and Drug Administration on April 6, 2007 due to unproven efficacy.[1]

See also


External links

  • Tebamide (manufacturer's website)
  • Tigan (manufacturer's website)

Got something to say? Make a comment.
Your name
Your email address